Solventum Corp | SOLV - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Cencora USD 955.61M 59.33M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Insulet USD 113M 27.2M 2026-03
Solventum Corp USD 332M 179M 2025-12
West Pharmaceutical Services USD 161.5M 8.6M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12